nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—NQO1—hematologic cancer	0.0579	0.174	CbGaD
Cisplatin—ABCC3—hematologic cancer	0.057	0.171	CbGaD
Cisplatin—GSTT1—hematologic cancer	0.0542	0.162	CbGaD
Cisplatin—GSTM1—hematologic cancer	0.0463	0.139	CbGaD
Cisplatin—GSTM1—Busulfan—hematologic cancer	0.0436	0.103	CbGbCtD
Cisplatin—GSTP1—hematologic cancer	0.0428	0.128	CbGaD
Cisplatin—SLC31A1—Bortezomib—hematologic cancer	0.0398	0.0944	CbGbCtD
Cisplatin—MPO—hematologic cancer	0.0361	0.108	CbGaD
Cisplatin—GSTP1—Busulfan—hematologic cancer	0.0315	0.0748	CbGbCtD
Cisplatin—GSTP1—Chlorambucil—hematologic cancer	0.0281	0.0667	CbGbCtD
Cisplatin—ABCG2—hematologic cancer	0.0277	0.083	CbGaD
Cisplatin—XDH—Procarbazine—hematologic cancer	0.0213	0.0505	CbGbCtD
Cisplatin—ABCC6—Daunorubicin—hematologic cancer	0.0183	0.0434	CbGbCtD
Cisplatin—ABCC6—Teniposide—hematologic cancer	0.0159	0.0377	CbGbCtD
Cisplatin—GSTT1—Etoposide—hematologic cancer	0.0122	0.0289	CbGbCtD
Cisplatin—ABCB1—hematologic cancer	0.0115	0.0345	CbGaD
Cisplatin—XDH—Daunorubicin—hematologic cancer	0.0114	0.0271	CbGbCtD
Cisplatin—ABCC5—Mercaptopurine—hematologic cancer	0.0108	0.0257	CbGbCtD
Cisplatin—XDH—Mercaptopurine—hematologic cancer	0.00885	0.021	CbGbCtD
Cisplatin—ABCC6—Vinblastine—hematologic cancer	0.00778	0.0184	CbGbCtD
Cisplatin—GSTP1—Etoposide—hematologic cancer	0.00762	0.0181	CbGbCtD
Cisplatin—ABCC6—Etoposide—hematologic cancer	0.00701	0.0166	CbGbCtD
Cisplatin—PTGS2—Lenalidomide—hematologic cancer	0.00673	0.016	CbGbCtD
Cisplatin—ABCG2—Clofarabine—hematologic cancer	0.00616	0.0146	CbGbCtD
Cisplatin—CYP4A11—Dexamethasone—hematologic cancer	0.00576	0.0137	CbGbCtD
Cisplatin—NQO1—Doxorubicin—hematologic cancer	0.00571	0.0135	CbGbCtD
Cisplatin—SLC22A2—Daunorubicin—hematologic cancer	0.00489	0.0116	CbGbCtD
Cisplatin—ABCC6—Doxorubicin—hematologic cancer	0.00478	0.0113	CbGbCtD
Cisplatin—SLC22A2—Cytarabine—hematologic cancer	0.00431	0.0102	CbGbCtD
Cisplatin—SLC22A2—Cladribine—hematologic cancer	0.00407	0.00966	CbGbCtD
Cisplatin—ABCC2—Daunorubicin—hematologic cancer	0.00399	0.00947	CbGbCtD
Cisplatin—SLC22A2—Imatinib—hematologic cancer	0.00375	0.00888	CbGbCtD
Cisplatin—ABCC3—Vincristine—hematologic cancer	0.00367	0.00871	CbGbCtD
Cisplatin—ABCG2—Daunorubicin—hematologic cancer	0.00361	0.00856	CbGbCtD
Cisplatin—PTGS2—Thalidomide—hematologic cancer	0.00359	0.00852	CbGbCtD
Cisplatin—CYP2B6—Thiotepa—hematologic cancer	0.00359	0.00851	CbGbCtD
Cisplatin—ABCC3—Etoposide—hematologic cancer	0.00337	0.00798	CbGbCtD
Cisplatin—BCHE—Triamcinolone—hematologic cancer	0.00324	0.00768	CbGbCtD
Cisplatin—ABCG2—Teniposide—hematologic cancer	0.00314	0.00744	CbGbCtD
Cisplatin—ABCG2—Cladribine—hematologic cancer	0.00301	0.00713	CbGbCtD
Cisplatin—XDH—Doxorubicin—hematologic cancer	0.00299	0.00708	CbGbCtD
Cisplatin—ABCG2—Imatinib—hematologic cancer	0.00276	0.00656	CbGbCtD
Cisplatin—ABCG2—Nilotinib—hematologic cancer	0.00251	0.00596	CbGbCtD
Cisplatin—PTGS2—Triamcinolone—hematologic cancer	0.00249	0.00591	CbGbCtD
Cisplatin—BCHE—Irinotecan—hematologic cancer	0.00245	0.00582	CbGbCtD
Cisplatin—ABCC3—Doxorubicin—hematologic cancer	0.0023	0.00545	CbGbCtD
Cisplatin—CYP2C9—Bexarotene—hematologic cancer	0.00229	0.00543	CbGbCtD
Cisplatin—ABCC3—Methotrexate—hematologic cancer	0.00222	0.00528	CbGbCtD
Cisplatin—ABCG2—Dasatinib—hematologic cancer	0.00222	0.00527	CbGbCtD
Cisplatin—ABCB1—Lenalidomide—hematologic cancer	0.00222	0.00526	CbGbCtD
Cisplatin—ABCG2—Mitoxantrone—hematologic cancer	0.00219	0.0052	CbGbCtD
Cisplatin—PTGS2—Betamethasone—hematologic cancer	0.00214	0.00507	CbGbCtD
Cisplatin—SLC22A2—Vinblastine—hematologic cancer	0.00208	0.00493	CbGbCtD
Cisplatin—CYP2B6—Ifosfamide—hematologic cancer	0.00204	0.00483	CbGbCtD
Cisplatin—ABCC2—Irinotecan—hematologic cancer	0.00191	0.00453	CbGbCtD
Cisplatin—CYP2C9—Idarubicin—hematologic cancer	0.0019	0.0045	CbGbCtD
Cisplatin—CYP2B6—Nilotinib—hematologic cancer	0.00177	0.00419	CbGbCtD
Cisplatin—ABCG2—Irinotecan—hematologic cancer	0.00173	0.0041	CbGbCtD
Cisplatin—ABCC2—Vinblastine—hematologic cancer	0.0017	0.00403	CbGbCtD
Cisplatin—ABCC2—Vincristine—hematologic cancer	0.00167	0.00396	CbGbCtD
Cisplatin—PTGS2—ovarian follicle—hematologic cancer	0.00167	0.0432	CbGeAlD
Cisplatin—ABCC2—Etoposide—hematologic cancer	0.00153	0.00363	CbGbCtD
Cisplatin—PTGS2—Etoposide—hematologic cancer	0.00151	0.00359	CbGbCtD
Cisplatin—ABCG2—Vincristine—hematologic cancer	0.00151	0.00358	CbGbCtD
Cisplatin—CYP2C9—Bortezomib—hematologic cancer	0.0014	0.00333	CbGbCtD
Cisplatin—ABCG2—Etoposide—hematologic cancer	0.00138	0.00328	CbGbCtD
Cisplatin—ABCB1—Daunorubicin—hematologic cancer	0.0013	0.00309	CbGbCtD
Cisplatin—ABCB1—Alitretinoin—hematologic cancer	0.00127	0.00302	CbGbCtD
Cisplatin—ABCC2—Dexamethasone—hematologic cancer	0.00126	0.00298	CbGbCtD
Cisplatin—PTGS2—Dexamethasone—hematologic cancer	0.00124	0.00295	CbGbCtD
Cisplatin—CYP2C9—Thalidomide—hematologic cancer	0.00122	0.0029	CbGbCtD
Cisplatin—CYP2B6—Irinotecan—hematologic cancer	0.00121	0.00288	CbGbCtD
Cisplatin—CYP2C9—Teniposide—hematologic cancer	0.00117	0.00276	CbGbCtD
Cisplatin—ABCG2—Dexamethasone—hematologic cancer	0.00114	0.0027	CbGbCtD
Cisplatin—CYP2C9—Ifosfamide—hematologic cancer	0.00108	0.00255	CbGbCtD
Cisplatin—ABCC2—Doxorubicin—hematologic cancer	0.00104	0.00247	CbGbCtD
Cisplatin—ATP7B—hematopoietic system—hematologic cancer	0.00103	0.0266	CbGeAlD
Cisplatin—CYP2C9—Imatinib—hematologic cancer	0.00103	0.00244	CbGbCtD
Cisplatin—ABCC2—Methotrexate—hematologic cancer	0.00101	0.0024	CbGbCtD
Cisplatin—ABCB1—Imatinib—hematologic cancer	0.000997	0.00236	CbGbCtD
Cisplatin—MT2A—hematopoietic system—hematologic cancer	0.000955	0.0247	CbGeAlD
Cisplatin—ABCG2—Doxorubicin—hematologic cancer	0.000943	0.00224	CbGbCtD
Cisplatin—SLC31A2—hematopoietic system—hematologic cancer	0.000939	0.0243	CbGeAlD
Cisplatin—GSTT1—hematopoietic system—hematologic cancer	0.000935	0.0242	CbGeAlD
Cisplatin—CYP2C9—Nilotinib—hematologic cancer	0.000933	0.00221	CbGbCtD
Cisplatin—ABCG2—Methotrexate—hematologic cancer	0.000914	0.00217	CbGbCtD
Cisplatin—ABCB1—Nilotinib—hematologic cancer	0.000906	0.00215	CbGbCtD
Cisplatin—ABCB1—Vinorelbine—hematologic cancer	0.000898	0.00213	CbGbCtD
Cisplatin—ABCB1—Dasatinib—hematologic cancer	0.000801	0.0019	CbGbCtD
Cisplatin—CYP2B6—Dexamethasone—hematologic cancer	0.0008	0.0019	CbGbCtD
Cisplatin—ABCB1—Mitoxantrone—hematologic cancer	0.000791	0.00188	CbGbCtD
Cisplatin—ABCC6—hematopoietic system—hematologic cancer	0.000759	0.0197	CbGeAlD
Cisplatin—MT2A—gonad—hematologic cancer	0.000726	0.0188	CbGeAlD
Cisplatin—ABCB1—Betamethasone—hematologic cancer	0.000705	0.00167	CbGbCtD
Cisplatin—ABCB1—Gemcitabine—hematologic cancer	0.000699	0.00166	CbGbCtD
Cisplatin—ABCB1—Prednisolone—hematologic cancer	0.000695	0.00165	CbGbCtD
Cisplatin—GSTM1—hematopoietic system—hematologic cancer	0.000689	0.0178	CbGeAlD
Cisplatin—ATP7B—blood—hematologic cancer	0.000681	0.0176	CbGeAlD
Cisplatin—MT1A—lung—hematologic cancer	0.000666	0.0173	CbGeAlD
Cisplatin—CYP2B6—Doxorubicin—hematologic cancer	0.000663	0.00157	CbGbCtD
Cisplatin—ABCB1—Prednisone—hematologic cancer	0.000657	0.00156	CbGbCtD
Cisplatin—MT1A—testis—hematologic cancer	0.000628	0.0163	CbGeAlD
Cisplatin—ABCB1—Irinotecan—hematologic cancer	0.000623	0.00148	CbGbCtD
Cisplatin—SLC31A2—blood—hematologic cancer	0.000622	0.0161	CbGeAlD
Cisplatin—GSTT1—blood—hematologic cancer	0.000619	0.016	CbGeAlD
Cisplatin—SLC31A2—bone marrow—hematologic cancer	0.000602	0.0156	CbGeAlD
Cisplatin—ATP7B—lung—hematologic cancer	0.000597	0.0155	CbGeAlD
Cisplatin—ATP7B—testis—hematologic cancer	0.000563	0.0146	CbGeAlD
Cisplatin—MT2A—lung—hematologic cancer	0.000555	0.0144	CbGeAlD
Cisplatin—ABCB1—Vinblastine—hematologic cancer	0.000554	0.00131	CbGbCtD
Cisplatin—ATP7A—blood—hematologic cancer	0.000548	0.0142	CbGeAlD
Cisplatin—SLC31A2—lung—hematologic cancer	0.000545	0.0141	CbGeAlD
Cisplatin—ABCB1—Vincristine—hematologic cancer	0.000544	0.00129	CbGbCtD
Cisplatin—GSTT1—lung—hematologic cancer	0.000543	0.0141	CbGeAlD
Cisplatin—SLC31A1—gonad—hematologic cancer	0.000536	0.0139	CbGeAlD
Cisplatin—ATP7A—bone marrow—hematologic cancer	0.00053	0.0137	CbGeAlD
Cisplatin—GSTM1—gonad—hematologic cancer	0.000524	0.0136	CbGeAlD
Cisplatin—MT2A—testis—hematologic cancer	0.000523	0.0136	CbGeAlD
Cisplatin—MT2A—Ponatinib—Nilotinib—hematologic cancer	0.000516	0.276	CbGdCrCtD
Cisplatin—SLC31A2—testis—hematologic cancer	0.000514	0.0133	CbGeAlD
Cisplatin—ABCC6—blood—hematologic cancer	0.000503	0.013	CbGeAlD
Cisplatin—ABCB1—Etoposide—hematologic cancer	0.000499	0.00118	CbGbCtD
Cisplatin—NQO1—hematopoietic system—hematologic cancer	0.000483	0.0125	CbGeAlD
Cisplatin—ATP7A—lung—hematologic cancer	0.00048	0.0124	CbGeAlD
Cisplatin—SOD1—blood—hematologic cancer	0.00048	0.0124	CbGeAlD
Cisplatin—SLC31A1—blood—hematologic cancer	0.000467	0.0121	CbGeAlD
Cisplatin—SOD1—bone marrow—hematologic cancer	0.000464	0.012	CbGeAlD
Cisplatin—GSTM1—blood—hematologic cancer	0.000456	0.0118	CbGeAlD
Cisplatin—MT1A—lymph node—hematologic cancer	0.000455	0.0118	CbGeAlD
Cisplatin—ATP7A—testis—hematologic cancer	0.000453	0.0117	CbGeAlD
Cisplatin—SLC31A1—bone marrow—hematologic cancer	0.000452	0.0117	CbGeAlD
Cisplatin—MPO—hematopoietic system—hematologic cancer	0.000444	0.0115	CbGeAlD
Cisplatin—ABCC6—lung—hematologic cancer	0.000441	0.0114	CbGeAlD
Cisplatin—ABCC3—hematopoietic system—hematologic cancer	0.000433	0.0112	CbGeAlD
Cisplatin—GSTP1—hematopoietic system—hematologic cancer	0.000431	0.0112	CbGeAlD
Cisplatin—CYP2C9—Dexamethasone—hematologic cancer	0.000422	0.001	CbGbCtD
Cisplatin—SOD1—lung—hematologic cancer	0.00042	0.0109	CbGeAlD
Cisplatin—ABCB1—Dexamethasone—hematologic cancer	0.00041	0.000972	CbGbCtD
Cisplatin—SLC31A1—lung—hematologic cancer	0.00041	0.0106	CbGeAlD
Cisplatin—ATP7B—lymph node—hematologic cancer	0.000408	0.0106	CbGeAlD
Cisplatin—GSTM1—lung—hematologic cancer	0.0004	0.0104	CbGeAlD
Cisplatin—SOD1—testis—hematologic cancer	0.000397	0.0103	CbGeAlD
Cisplatin—MT2A—Ponatinib—Imatinib—hematologic cancer	0.000391	0.209	CbGdCrCtD
Cisplatin—SLC31A1—testis—hematologic cancer	0.000387	0.01	CbGeAlD
Cisplatin—GSTM1—testis—hematologic cancer	0.000377	0.00978	CbGeAlD
Cisplatin—SLC31A2—lymph node—hematologic cancer	0.000373	0.00966	CbGeAlD
Cisplatin—ABCB1—Doxorubicin—hematologic cancer	0.00034	0.000807	CbGbCtD
Cisplatin—ABCC5—bone marrow—hematologic cancer	0.000331	0.00857	CbGeAlD
Cisplatin—ABCB1—Methotrexate—hematologic cancer	0.000329	0.000782	CbGbCtD
Cisplatin—ATP7A—lymph node—hematologic cancer	0.000329	0.00851	CbGeAlD
Cisplatin—GSTP1—gonad—hematologic cancer	0.000328	0.0085	CbGeAlD
Cisplatin—ABCC5—lung—hematologic cancer	0.0003	0.00776	CbGeAlD
Cisplatin—MPO—blood—hematologic cancer	0.000294	0.00762	CbGeAlD
Cisplatin—SOD1—lymph node—hematologic cancer	0.000288	0.00745	CbGeAlD
Cisplatin—ABCC3—blood—hematologic cancer	0.000287	0.00744	CbGeAlD
Cisplatin—ABCC6—Podofilox—Teniposide—hematologic cancer	0.000287	0.153	CbGdCrCtD
Cisplatin—GSTP1—blood—hematologic cancer	0.000286	0.0074	CbGeAlD
Cisplatin—MPO—bone marrow—hematologic cancer	0.000284	0.00737	CbGeAlD
Cisplatin—ABCC5—testis—hematologic cancer	0.000283	0.00732	CbGeAlD
Cisplatin—NQO1—lung—hematologic cancer	0.00028	0.00726	CbGeAlD
Cisplatin—SLC31A1—lymph node—hematologic cancer	0.00028	0.00726	CbGeAlD
Cisplatin—GSTP1—bone marrow—hematologic cancer	0.000276	0.00716	CbGeAlD
Cisplatin—GSTM1—lymph node—hematologic cancer	0.000274	0.00709	CbGeAlD
Cisplatin—NQO1—testis—hematologic cancer	0.000264	0.00685	CbGeAlD
Cisplatin—BCHE—hematopoietic system—hematologic cancer	0.000261	0.00677	CbGeAlD
Cisplatin—MPO—lung—hematologic cancer	0.000258	0.00668	CbGeAlD
Cisplatin—ABCC3—lung—hematologic cancer	0.000252	0.00652	CbGeAlD
Cisplatin—GSTP1—lung—hematologic cancer	0.00025	0.00649	CbGeAlD
Cisplatin—MPO—testis—hematologic cancer	0.000243	0.0063	CbGeAlD
Cisplatin—ABCC3—testis—hematologic cancer	0.000237	0.00615	CbGeAlD
Cisplatin—GSTP1—testis—hematologic cancer	0.000236	0.00612	CbGeAlD
Cisplatin—CYP2B6—hematopoietic system—hematologic cancer	0.000233	0.00603	CbGeAlD
Cisplatin—CYP2C9—hematopoietic system—hematologic cancer	0.000231	0.00597	CbGeAlD
Cisplatin—ABCC2—blood—hematologic cancer	0.000229	0.00594	CbGeAlD
Cisplatin—ABCC5—lymph node—hematologic cancer	0.000205	0.00531	CbGeAlD
Cisplatin—PTGS2—hematopoietic system—hematologic cancer	0.000201	0.00521	CbGeAlD
Cisplatin—NQO1—Vincristine—Vinorelbine—hematologic cancer	0.0002	0.107	CbGdCrCtD
Cisplatin—NQO1—lymph node—hematologic cancer	0.000192	0.00497	CbGeAlD
Cisplatin—ABCC2—testis—hematologic cancer	0.00019	0.00491	CbGeAlD
Cisplatin—CYP2B6—gonad—hematologic cancer	0.000177	0.00459	CbGeAlD
Cisplatin—MPO—lymph node—hematologic cancer	0.000176	0.00457	CbGeAlD
Cisplatin—BCHE—blood—hematologic cancer	0.000173	0.00448	CbGeAlD
Cisplatin—ABCC3—lymph node—hematologic cancer	0.000172	0.00446	CbGeAlD
Cisplatin—GSTP1—lymph node—hematologic cancer	0.000171	0.00444	CbGeAlD
Cisplatin—ABCC6—Podofilox—Etoposide—hematologic cancer	0.00017	0.0911	CbGdCrCtD
Cisplatin—BCHE—bone marrow—hematologic cancer	0.000167	0.00434	CbGeAlD
Cisplatin—ABCG2—blood—hematologic cancer	0.000167	0.00433	CbGeAlD
Cisplatin—ABCG2—bone marrow—hematologic cancer	0.000162	0.00419	CbGeAlD
Cisplatin—NQO1—Vincristine—Vinblastine—hematologic cancer	0.000159	0.0852	CbGdCrCtD
Cisplatin—CYP2B6—blood—hematologic cancer	0.000154	0.004	CbGeAlD
Cisplatin—CYP2C9—blood—hematologic cancer	0.000153	0.00396	CbGeAlD
Cisplatin—BCHE—lung—hematologic cancer	0.000152	0.00393	CbGeAlD
Cisplatin—ABCG2—lung—hematologic cancer	0.000147	0.0038	CbGeAlD
Cisplatin—BCHE—testis—hematologic cancer	0.000143	0.00371	CbGeAlD
Cisplatin—ABCG2—testis—hematologic cancer	0.000138	0.00358	CbGeAlD
Cisplatin—ABCC2—lymph node—hematologic cancer	0.000137	0.00356	CbGeAlD
Cisplatin—CYP2B6—lung—hematologic cancer	0.000135	0.0035	CbGeAlD
Cisplatin—PTGS2—blood—hematologic cancer	0.000133	0.00345	CbGeAlD
Cisplatin—PTGS2—bone marrow—hematologic cancer	0.000129	0.00334	CbGeAlD
Cisplatin—CYP2B6—testis—hematologic cancer	0.000128	0.00331	CbGeAlD
Cisplatin—ABCB1—hematopoietic system—hematologic cancer	0.000124	0.00322	CbGeAlD
Cisplatin—PTGS2—lung—hematologic cancer	0.000117	0.00303	CbGeAlD
Cisplatin—BCHE—lymph node—hematologic cancer	0.000104	0.00269	CbGeAlD
Cisplatin—ABCG2—lymph node—hematologic cancer	0.0001	0.0026	CbGeAlD
Cisplatin—ABCB1—gonad—hematologic cancer	9.46e-05	0.00245	CbGeAlD
Cisplatin—ABCB1—blood—hematologic cancer	8.25e-05	0.00214	CbGeAlD
Cisplatin—PTGS2—lymph node—hematologic cancer	7.99e-05	0.00207	CbGeAlD
Cisplatin—ABCB1—bone marrow—hematologic cancer	7.98e-05	0.00207	CbGeAlD
Cisplatin—ABCB1—lung—hematologic cancer	7.23e-05	0.00187	CbGeAlD
Cisplatin—ABCB1—testis—hematologic cancer	6.82e-05	0.00177	CbGeAlD
Cisplatin—ABCB1—lymph node—hematologic cancer	4.94e-05	0.00128	CbGeAlD
Cisplatin—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	3.1e-05	0.0166	CbGdCrCtD
Cisplatin—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	3.1e-05	0.0166	CbGdCrCtD
Cisplatin—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	3.03e-05	0.0162	CbGdCrCtD
Cisplatin—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	1.87e-05	0.01	CbGdCrCtD
Cisplatin—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	1.87e-05	0.01	CbGdCrCtD
Cisplatin—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	1.83e-05	0.00977	CbGdCrCtD
Cisplatin—Diarrhoea—Gemcitabine—hematologic cancer	1.07e-05	8.33e-05	CcSEcCtD
Cisplatin—Nausea—Thalidomide—hematologic cancer	1.07e-05	8.31e-05	CcSEcCtD
Cisplatin—Renal failure—Doxorubicin—hematologic cancer	1.06e-05	8.31e-05	CcSEcCtD
Cisplatin—Rash—Ifosfamide—hematologic cancer	1.06e-05	8.3e-05	CcSEcCtD
Cisplatin—Dermatitis—Ifosfamide—hematologic cancer	1.06e-05	8.29e-05	CcSEcCtD
Cisplatin—Neuropathy peripheral—Doxorubicin—hematologic cancer	1.06e-05	8.29e-05	CcSEcCtD
Cisplatin—Hyperhidrosis—Betamethasone—hematologic cancer	1.06e-05	8.27e-05	CcSEcCtD
Cisplatin—Hyperhidrosis—Dexamethasone—hematologic cancer	1.06e-05	8.27e-05	CcSEcCtD
Cisplatin—Stomatitis—Doxorubicin—hematologic cancer	1.06e-05	8.24e-05	CcSEcCtD
Cisplatin—Malaise—Prednisone—hematologic cancer	1.05e-05	8.23e-05	CcSEcCtD
Cisplatin—Body temperature increased—Etoposide—hematologic cancer	1.05e-05	8.22e-05	CcSEcCtD
Cisplatin—Conjunctivitis—Doxorubicin—hematologic cancer	1.05e-05	8.22e-05	CcSEcCtD
Cisplatin—Eye disorder—Methotrexate—hematologic cancer	1.05e-05	8.19e-05	CcSEcCtD
Cisplatin—Tinnitus—Methotrexate—hematologic cancer	1.05e-05	8.17e-05	CcSEcCtD
Cisplatin—Vomiting—Vincristine—hematologic cancer	1.05e-05	8.16e-05	CcSEcCtD
Cisplatin—Anorexia—Dexamethasone—hematologic cancer	1.05e-05	8.15e-05	CcSEcCtD
Cisplatin—Anorexia—Betamethasone—hematologic cancer	1.05e-05	8.15e-05	CcSEcCtD
Cisplatin—Cardiac disorder—Methotrexate—hematologic cancer	1.04e-05	8.13e-05	CcSEcCtD
Cisplatin—Urinary tract disorder—Epirubicin—hematologic cancer	1.04e-05	8.1e-05	CcSEcCtD
Cisplatin—Rash—Vincristine—hematologic cancer	1.04e-05	8.09e-05	CcSEcCtD
Cisplatin—Dermatitis—Vincristine—hematologic cancer	1.04e-05	8.08e-05	CcSEcCtD
Cisplatin—Pain—Triamcinolone—hematologic cancer	1.03e-05	8.06e-05	CcSEcCtD
Cisplatin—Connective tissue disorder—Epirubicin—hematologic cancer	1.03e-05	8.06e-05	CcSEcCtD
Cisplatin—Urethral disorder—Epirubicin—hematologic cancer	1.03e-05	8.04e-05	CcSEcCtD
Cisplatin—Hepatobiliary disease—Doxorubicin—hematologic cancer	1.02e-05	7.99e-05	CcSEcCtD
Cisplatin—Hypotension—Betamethasone—hematologic cancer	1.02e-05	7.99e-05	CcSEcCtD
Cisplatin—Hypotension—Dexamethasone—hematologic cancer	1.02e-05	7.99e-05	CcSEcCtD
Cisplatin—Nausea—Carmustine—hematologic cancer	1.02e-05	7.98e-05	CcSEcCtD
Cisplatin—Vomiting—Mitoxantrone—hematologic cancer	1.02e-05	7.95e-05	CcSEcCtD
Cisplatin—Vomiting—Irinotecan—hematologic cancer	1.02e-05	7.95e-05	CcSEcCtD
Cisplatin—Immune system disorder—Methotrexate—hematologic cancer	1.01e-05	7.92e-05	CcSEcCtD
Cisplatin—Nausea—Alitretinoin—hematologic cancer	1.01e-05	7.91e-05	CcSEcCtD
Cisplatin—Convulsion—Prednisone—hematologic cancer	1.01e-05	7.91e-05	CcSEcCtD
Cisplatin—Visual impairment—Epirubicin—hematologic cancer	1.01e-05	7.9e-05	CcSEcCtD
Cisplatin—Mediastinal disorder—Methotrexate—hematologic cancer	1.01e-05	7.9e-05	CcSEcCtD
Cisplatin—Rash—Irinotecan—hematologic cancer	1.01e-05	7.88e-05	CcSEcCtD
Cisplatin—Rash—Mitoxantrone—hematologic cancer	1.01e-05	7.88e-05	CcSEcCtD
Cisplatin—Dermatitis—Mitoxantrone—hematologic cancer	1.01e-05	7.87e-05	CcSEcCtD
Cisplatin—Dermatitis—Irinotecan—hematologic cancer	1.01e-05	7.87e-05	CcSEcCtD
Cisplatin—Nausea—Ifosfamide—hematologic cancer	1e-05	7.82e-05	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	9.99e-06	7.79e-05	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Betamethasone—hematologic cancer	9.99e-06	7.79e-05	CcSEcCtD
Cisplatin—Myalgia—Prednisone—hematologic cancer	9.96e-06	7.77e-05	CcSEcCtD
Cisplatin—Feeling abnormal—Triamcinolone—hematologic cancer	9.96e-06	7.77e-05	CcSEcCtD
Cisplatin—Anxiety—Prednisone—hematologic cancer	9.93e-06	7.74e-05	CcSEcCtD
Cisplatin—Alopecia—Methotrexate—hematologic cancer	9.92e-06	7.74e-05	CcSEcCtD
Cisplatin—Vomiting—Gemcitabine—hematologic cancer	9.92e-06	7.74e-05	CcSEcCtD
Cisplatin—Bradycardia—Doxorubicin—hematologic cancer	9.9e-06	7.73e-05	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	9.89e-06	7.72e-05	CcSEcCtD
Cisplatin—Paraesthesia—Dexamethasone—hematologic cancer	9.84e-06	7.68e-05	CcSEcCtD
Cisplatin—Paraesthesia—Betamethasone—hematologic cancer	9.84e-06	7.68e-05	CcSEcCtD
Cisplatin—Discomfort—Prednisone—hematologic cancer	9.84e-06	7.68e-05	CcSEcCtD
Cisplatin—Rash—Gemcitabine—hematologic cancer	9.84e-06	7.68e-05	CcSEcCtD
Cisplatin—Dermatitis—Gemcitabine—hematologic cancer	9.83e-06	7.67e-05	CcSEcCtD
Cisplatin—Eye disorder—Epirubicin—hematologic cancer	9.82e-06	7.66e-05	CcSEcCtD
Cisplatin—Hypersensitivity—Etoposide—hematologic cancer	9.81e-06	7.66e-05	CcSEcCtD
Cisplatin—Tinnitus—Epirubicin—hematologic cancer	9.8e-06	7.65e-05	CcSEcCtD
Cisplatin—Erythema—Methotrexate—hematologic cancer	9.78e-06	7.63e-05	CcSEcCtD
Cisplatin—Malnutrition—Methotrexate—hematologic cancer	9.78e-06	7.63e-05	CcSEcCtD
Cisplatin—Nausea—Vincristine—hematologic cancer	9.77e-06	7.62e-05	CcSEcCtD
Cisplatin—Flushing—Epirubicin—hematologic cancer	9.75e-06	7.61e-05	CcSEcCtD
Cisplatin—Cardiac disorder—Epirubicin—hematologic cancer	9.75e-06	7.61e-05	CcSEcCtD
Cisplatin—Hypersensitivity—Prednisolone—hematologic cancer	9.68e-06	7.55e-05	CcSEcCtD
Cisplatin—Urinary tract disorder—Doxorubicin—hematologic cancer	9.6e-06	7.49e-05	CcSEcCtD
Cisplatin—Asthenia—Etoposide—hematologic cancer	9.56e-06	7.46e-05	CcSEcCtD
Cisplatin—Connective tissue disorder—Doxorubicin—hematologic cancer	9.56e-06	7.46e-05	CcSEcCtD
Cisplatin—Body temperature increased—Triamcinolone—hematologic cancer	9.55e-06	7.45e-05	CcSEcCtD
Cisplatin—Anaphylactic shock—Prednisone—hematologic cancer	9.55e-06	7.45e-05	CcSEcCtD
Cisplatin—Oedema—Prednisone—hematologic cancer	9.55e-06	7.45e-05	CcSEcCtD
Cisplatin—Urethral disorder—Doxorubicin—hematologic cancer	9.53e-06	7.44e-05	CcSEcCtD
Cisplatin—Decreased appetite—Betamethasone—hematologic cancer	9.53e-06	7.44e-05	CcSEcCtD
Cisplatin—Decreased appetite—Dexamethasone—hematologic cancer	9.53e-06	7.44e-05	CcSEcCtD
Cisplatin—Nausea—Mitoxantrone—hematologic cancer	9.51e-06	7.42e-05	CcSEcCtD
Cisplatin—Nausea—Irinotecan—hematologic cancer	9.51e-06	7.42e-05	CcSEcCtD
Cisplatin—Immune system disorder—Epirubicin—hematologic cancer	9.49e-06	7.41e-05	CcSEcCtD
Cisplatin—Infection—Prednisone—hematologic cancer	9.49e-06	7.4e-05	CcSEcCtD
Cisplatin—Mediastinal disorder—Epirubicin—hematologic cancer	9.47e-06	7.39e-05	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Betamethasone—hematologic cancer	9.47e-06	7.39e-05	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	9.47e-06	7.39e-05	CcSEcCtD
Cisplatin—Arrhythmia—Epirubicin—hematologic cancer	9.39e-06	7.33e-05	CcSEcCtD
Cisplatin—Pain—Betamethasone—hematologic cancer	9.38e-06	7.32e-05	CcSEcCtD
Cisplatin—Pain—Dexamethasone—hematologic cancer	9.38e-06	7.32e-05	CcSEcCtD
Cisplatin—Visual impairment—Doxorubicin—hematologic cancer	9.37e-06	7.31e-05	CcSEcCtD
Cisplatin—Nervous system disorder—Prednisone—hematologic cancer	9.36e-06	7.31e-05	CcSEcCtD
Cisplatin—Tachycardia—Prednisone—hematologic cancer	9.32e-06	7.27e-05	CcSEcCtD
Cisplatin—Alopecia—Epirubicin—hematologic cancer	9.29e-06	7.25e-05	CcSEcCtD
Cisplatin—Skin disorder—Prednisone—hematologic cancer	9.27e-06	7.24e-05	CcSEcCtD
Cisplatin—Nausea—Gemcitabine—hematologic cancer	9.27e-06	7.23e-05	CcSEcCtD
Cisplatin—Hyperhidrosis—Prednisone—hematologic cancer	9.23e-06	7.2e-05	CcSEcCtD
Cisplatin—Vision blurred—Methotrexate—hematologic cancer	9.21e-06	7.19e-05	CcSEcCtD
Cisplatin—Malnutrition—Epirubicin—hematologic cancer	9.15e-06	7.14e-05	CcSEcCtD
Cisplatin—Erythema—Epirubicin—hematologic cancer	9.15e-06	7.14e-05	CcSEcCtD
Cisplatin—Diarrhoea—Etoposide—hematologic cancer	9.11e-06	7.11e-05	CcSEcCtD
Cisplatin—Anorexia—Prednisone—hematologic cancer	9.1e-06	7.1e-05	CcSEcCtD
Cisplatin—Eye disorder—Doxorubicin—hematologic cancer	9.09e-06	7.09e-05	CcSEcCtD
Cisplatin—Ill-defined disorder—Methotrexate—hematologic cancer	9.07e-06	7.08e-05	CcSEcCtD
Cisplatin—Tinnitus—Doxorubicin—hematologic cancer	9.07e-06	7.08e-05	CcSEcCtD
Cisplatin—Anaemia—Methotrexate—hematologic cancer	9.04e-06	7.05e-05	CcSEcCtD
Cisplatin—Feeling abnormal—Dexamethasone—hematologic cancer	9.03e-06	7.05e-05	CcSEcCtD
Cisplatin—Feeling abnormal—Betamethasone—hematologic cancer	9.03e-06	7.05e-05	CcSEcCtD
Cisplatin—Flushing—Doxorubicin—hematologic cancer	9.03e-06	7.04e-05	CcSEcCtD
Cisplatin—Cardiac disorder—Doxorubicin—hematologic cancer	9.03e-06	7.04e-05	CcSEcCtD
Cisplatin—Flatulence—Epirubicin—hematologic cancer	9.02e-06	7.03e-05	CcSEcCtD
Cisplatin—Hypersensitivity—Triamcinolone—hematologic cancer	8.9e-06	6.95e-05	CcSEcCtD
Cisplatin—Malaise—Methotrexate—hematologic cancer	8.82e-06	6.88e-05	CcSEcCtD
Cisplatin—Muscle spasms—Epirubicin—hematologic cancer	8.8e-06	6.86e-05	CcSEcCtD
Cisplatin—Immune system disorder—Doxorubicin—hematologic cancer	8.78e-06	6.85e-05	CcSEcCtD
Cisplatin—Mediastinal disorder—Doxorubicin—hematologic cancer	8.76e-06	6.84e-05	CcSEcCtD
Cisplatin—Leukopenia—Methotrexate—hematologic cancer	8.75e-06	6.83e-05	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Prednisone—hematologic cancer	8.7e-06	6.79e-05	CcSEcCtD
Cisplatin—Arrhythmia—Doxorubicin—hematologic cancer	8.69e-06	6.78e-05	CcSEcCtD
Cisplatin—Asthenia—Triamcinolone—hematologic cancer	8.67e-06	6.76e-05	CcSEcCtD
Cisplatin—Body temperature increased—Dexamethasone—hematologic cancer	8.67e-06	6.76e-05	CcSEcCtD
Cisplatin—Body temperature increased—Betamethasone—hematologic cancer	8.67e-06	6.76e-05	CcSEcCtD
Cisplatin—Vision blurred—Epirubicin—hematologic cancer	8.62e-06	6.73e-05	CcSEcCtD
Cisplatin—Alopecia—Doxorubicin—hematologic cancer	8.59e-06	6.71e-05	CcSEcCtD
Cisplatin—Paraesthesia—Prednisone—hematologic cancer	8.57e-06	6.69e-05	CcSEcCtD
Cisplatin—Ill-defined disorder—Epirubicin—hematologic cancer	8.49e-06	6.62e-05	CcSEcCtD
Cisplatin—Convulsion—Methotrexate—hematologic cancer	8.47e-06	6.61e-05	CcSEcCtD
Cisplatin—Vomiting—Etoposide—hematologic cancer	8.47e-06	6.61e-05	CcSEcCtD
Cisplatin—Erythema—Doxorubicin—hematologic cancer	8.47e-06	6.61e-05	CcSEcCtD
Cisplatin—Malnutrition—Doxorubicin—hematologic cancer	8.47e-06	6.61e-05	CcSEcCtD
Cisplatin—Anaemia—Epirubicin—hematologic cancer	8.46e-06	6.6e-05	CcSEcCtD
Cisplatin—Rash—Etoposide—hematologic cancer	8.4e-06	6.55e-05	CcSEcCtD
Cisplatin—Dermatitis—Etoposide—hematologic cancer	8.39e-06	6.55e-05	CcSEcCtD
Cisplatin—Flatulence—Doxorubicin—hematologic cancer	8.34e-06	6.51e-05	CcSEcCtD
Cisplatin—Myalgia—Methotrexate—hematologic cancer	8.32e-06	6.49e-05	CcSEcCtD
Cisplatin—Decreased appetite—Prednisone—hematologic cancer	8.3e-06	6.48e-05	CcSEcCtD
Cisplatin—Rash—Prednisolone—hematologic cancer	8.28e-06	6.46e-05	CcSEcCtD
Cisplatin—Dermatitis—Prednisolone—hematologic cancer	8.28e-06	6.46e-05	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	8.27e-06	6.45e-05	CcSEcCtD
Cisplatin—Malaise—Epirubicin—hematologic cancer	8.25e-06	6.44e-05	CcSEcCtD
Cisplatin—Discomfort—Methotrexate—hematologic cancer	8.22e-06	6.42e-05	CcSEcCtD
Cisplatin—Leukopenia—Epirubicin—hematologic cancer	8.19e-06	6.39e-05	CcSEcCtD
Cisplatin—Muscle spasms—Doxorubicin—hematologic cancer	8.14e-06	6.35e-05	CcSEcCtD
Cisplatin—Anaphylactic shock—Methotrexate—hematologic cancer	7.98e-06	6.23e-05	CcSEcCtD
Cisplatin—Vision blurred—Doxorubicin—hematologic cancer	7.98e-06	6.23e-05	CcSEcCtD
Cisplatin—Convulsion—Epirubicin—hematologic cancer	7.93e-06	6.19e-05	CcSEcCtD
Cisplatin—Infection—Methotrexate—hematologic cancer	7.93e-06	6.19e-05	CcSEcCtD
Cisplatin—Nausea—Etoposide—hematologic cancer	7.91e-06	6.17e-05	CcSEcCtD
Cisplatin—Feeling abnormal—Prednisone—hematologic cancer	7.87e-06	6.14e-05	CcSEcCtD
Cisplatin—Asthenia—Dexamethasone—hematologic cancer	7.87e-06	6.14e-05	CcSEcCtD
Cisplatin—Asthenia—Betamethasone—hematologic cancer	7.87e-06	6.14e-05	CcSEcCtD
Cisplatin—Ill-defined disorder—Doxorubicin—hematologic cancer	7.86e-06	6.13e-05	CcSEcCtD
Cisplatin—Nervous system disorder—Methotrexate—hematologic cancer	7.83e-06	6.11e-05	CcSEcCtD
Cisplatin—Anaemia—Doxorubicin—hematologic cancer	7.82e-06	6.11e-05	CcSEcCtD
Cisplatin—Thrombocytopenia—Methotrexate—hematologic cancer	7.81e-06	6.1e-05	CcSEcCtD
Cisplatin—Nausea—Prednisolone—hematologic cancer	7.8e-06	6.09e-05	CcSEcCtD
Cisplatin—Myalgia—Epirubicin—hematologic cancer	7.79e-06	6.08e-05	CcSEcCtD
Cisplatin—Anxiety—Epirubicin—hematologic cancer	7.76e-06	6.06e-05	CcSEcCtD
Cisplatin—Skin disorder—Methotrexate—hematologic cancer	7.75e-06	6.05e-05	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	7.74e-06	6.04e-05	CcSEcCtD
Cisplatin—Hyperhidrosis—Methotrexate—hematologic cancer	7.71e-06	6.02e-05	CcSEcCtD
Cisplatin—Discomfort—Epirubicin—hematologic cancer	7.7e-06	6.01e-05	CcSEcCtD
Cisplatin—Vomiting—Triamcinolone—hematologic cancer	7.68e-06	5.99e-05	CcSEcCtD
Cisplatin—Malaise—Doxorubicin—hematologic cancer	7.63e-06	5.96e-05	CcSEcCtD
Cisplatin—Rash—Triamcinolone—hematologic cancer	7.62e-06	5.94e-05	CcSEcCtD
Cisplatin—Dermatitis—Triamcinolone—hematologic cancer	7.61e-06	5.94e-05	CcSEcCtD
Cisplatin—Anorexia—Methotrexate—hematologic cancer	7.61e-06	5.93e-05	CcSEcCtD
Cisplatin—Leukopenia—Doxorubicin—hematologic cancer	7.58e-06	5.91e-05	CcSEcCtD
Cisplatin—Body temperature increased—Prednisone—hematologic cancer	7.55e-06	5.89e-05	CcSEcCtD
Cisplatin—Diarrhoea—Dexamethasone—hematologic cancer	7.5e-06	5.85e-05	CcSEcCtD
Cisplatin—Diarrhoea—Betamethasone—hematologic cancer	7.5e-06	5.85e-05	CcSEcCtD
Cisplatin—Oedema—Epirubicin—hematologic cancer	7.47e-06	5.83e-05	CcSEcCtD
Cisplatin—Anaphylactic shock—Epirubicin—hematologic cancer	7.47e-06	5.83e-05	CcSEcCtD
Cisplatin—Hypotension—Methotrexate—hematologic cancer	7.46e-06	5.82e-05	CcSEcCtD
Cisplatin—Infection—Epirubicin—hematologic cancer	7.42e-06	5.79e-05	CcSEcCtD
Cisplatin—Convulsion—Doxorubicin—hematologic cancer	7.34e-06	5.72e-05	CcSEcCtD
Cisplatin—Nervous system disorder—Epirubicin—hematologic cancer	7.32e-06	5.71e-05	CcSEcCtD
Cisplatin—Thrombocytopenia—Epirubicin—hematologic cancer	7.31e-06	5.7e-05	CcSEcCtD
Cisplatin—Tachycardia—Epirubicin—hematologic cancer	7.29e-06	5.69e-05	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	7.27e-06	5.67e-05	CcSEcCtD
Cisplatin—Skin disorder—Epirubicin—hematologic cancer	7.25e-06	5.66e-05	CcSEcCtD
Cisplatin—Hyperhidrosis—Epirubicin—hematologic cancer	7.22e-06	5.63e-05	CcSEcCtD
Cisplatin—Myalgia—Doxorubicin—hematologic cancer	7.21e-06	5.62e-05	CcSEcCtD
Cisplatin—Anxiety—Doxorubicin—hematologic cancer	7.18e-06	5.6e-05	CcSEcCtD
Cisplatin—Nausea—Triamcinolone—hematologic cancer	7.18e-06	5.6e-05	CcSEcCtD
Cisplatin—Paraesthesia—Methotrexate—hematologic cancer	7.17e-06	5.59e-05	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	7.16e-06	5.59e-05	CcSEcCtD
Cisplatin—Discomfort—Doxorubicin—hematologic cancer	7.12e-06	5.56e-05	CcSEcCtD
Cisplatin—Anorexia—Epirubicin—hematologic cancer	7.12e-06	5.55e-05	CcSEcCtD
Cisplatin—Dyspnoea—Methotrexate—hematologic cancer	7.11e-06	5.55e-05	CcSEcCtD
Cisplatin—Hypersensitivity—Prednisone—hematologic cancer	7.03e-06	5.49e-05	CcSEcCtD
Cisplatin—Hypotension—Epirubicin—hematologic cancer	6.98e-06	5.44e-05	CcSEcCtD
Cisplatin—Vomiting—Betamethasone—hematologic cancer	6.97e-06	5.44e-05	CcSEcCtD
Cisplatin—Vomiting—Dexamethasone—hematologic cancer	6.97e-06	5.44e-05	CcSEcCtD
Cisplatin—Decreased appetite—Methotrexate—hematologic cancer	6.94e-06	5.41e-05	CcSEcCtD
Cisplatin—Rash—Dexamethasone—hematologic cancer	6.91e-06	5.39e-05	CcSEcCtD
Cisplatin—Rash—Betamethasone—hematologic cancer	6.91e-06	5.39e-05	CcSEcCtD
Cisplatin—Oedema—Doxorubicin—hematologic cancer	6.91e-06	5.39e-05	CcSEcCtD
Cisplatin—Anaphylactic shock—Doxorubicin—hematologic cancer	6.91e-06	5.39e-05	CcSEcCtD
Cisplatin—Dermatitis—Betamethasone—hematologic cancer	6.91e-06	5.39e-05	CcSEcCtD
Cisplatin—Dermatitis—Dexamethasone—hematologic cancer	6.91e-06	5.39e-05	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Methotrexate—hematologic cancer	6.89e-06	5.38e-05	CcSEcCtD
Cisplatin—Infection—Doxorubicin—hematologic cancer	6.86e-06	5.36e-05	CcSEcCtD
Cisplatin—Asthenia—Prednisone—hematologic cancer	6.85e-06	5.35e-05	CcSEcCtD
Cisplatin—Pain—Methotrexate—hematologic cancer	6.82e-06	5.32e-05	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	6.8e-06	5.31e-05	CcSEcCtD
Cisplatin—Nervous system disorder—Doxorubicin—hematologic cancer	6.78e-06	5.29e-05	CcSEcCtD
Cisplatin—Thrombocytopenia—Doxorubicin—hematologic cancer	6.77e-06	5.28e-05	CcSEcCtD
Cisplatin—Tachycardia—Doxorubicin—hematologic cancer	6.74e-06	5.26e-05	CcSEcCtD
Cisplatin—Skin disorder—Doxorubicin—hematologic cancer	6.71e-06	5.24e-05	CcSEcCtD
Cisplatin—Paraesthesia—Epirubicin—hematologic cancer	6.71e-06	5.23e-05	CcSEcCtD
Cisplatin—Hyperhidrosis—Doxorubicin—hematologic cancer	6.68e-06	5.21e-05	CcSEcCtD
Cisplatin—Dyspnoea—Epirubicin—hematologic cancer	6.66e-06	5.19e-05	CcSEcCtD
Cisplatin—Anorexia—Doxorubicin—hematologic cancer	6.59e-06	5.14e-05	CcSEcCtD
Cisplatin—Feeling abnormal—Methotrexate—hematologic cancer	6.58e-06	5.13e-05	CcSEcCtD
Cisplatin—Diarrhoea—Prednisone—hematologic cancer	6.53e-06	5.1e-05	CcSEcCtD
Cisplatin—Nausea—Dexamethasone—hematologic cancer	6.51e-06	5.08e-05	CcSEcCtD
Cisplatin—Nausea—Betamethasone—hematologic cancer	6.51e-06	5.08e-05	CcSEcCtD
Cisplatin—Decreased appetite—Epirubicin—hematologic cancer	6.49e-06	5.06e-05	CcSEcCtD
Cisplatin—Hypotension—Doxorubicin—hematologic cancer	6.46e-06	5.04e-05	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Epirubicin—hematologic cancer	6.45e-06	5.03e-05	CcSEcCtD
Cisplatin—Pain—Epirubicin—hematologic cancer	6.39e-06	4.98e-05	CcSEcCtD
Cisplatin—Body temperature increased—Methotrexate—hematologic cancer	6.31e-06	4.92e-05	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	6.29e-06	4.91e-05	CcSEcCtD
Cisplatin—Paraesthesia—Doxorubicin—hematologic cancer	6.2e-06	4.84e-05	CcSEcCtD
Cisplatin—Dyspnoea—Doxorubicin—hematologic cancer	6.16e-06	4.81e-05	CcSEcCtD
Cisplatin—Feeling abnormal—Epirubicin—hematologic cancer	6.15e-06	4.8e-05	CcSEcCtD
Cisplatin—Vomiting—Prednisone—hematologic cancer	6.07e-06	4.74e-05	CcSEcCtD
Cisplatin—Rash—Prednisone—hematologic cancer	6.02e-06	4.7e-05	CcSEcCtD
Cisplatin—Dermatitis—Prednisone—hematologic cancer	6.01e-06	4.69e-05	CcSEcCtD
Cisplatin—Decreased appetite—Doxorubicin—hematologic cancer	6.01e-06	4.69e-05	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	5.97e-06	4.65e-05	CcSEcCtD
Cisplatin—Pain—Doxorubicin—hematologic cancer	5.91e-06	4.61e-05	CcSEcCtD
Cisplatin—Body temperature increased—Epirubicin—hematologic cancer	5.9e-06	4.61e-05	CcSEcCtD
Cisplatin—Hypersensitivity—Methotrexate—hematologic cancer	5.88e-06	4.59e-05	CcSEcCtD
Cisplatin—Asthenia—Methotrexate—hematologic cancer	5.73e-06	4.47e-05	CcSEcCtD
Cisplatin—Feeling abnormal—Doxorubicin—hematologic cancer	5.69e-06	4.44e-05	CcSEcCtD
Cisplatin—Nausea—Prednisone—hematologic cancer	5.67e-06	4.43e-05	CcSEcCtD
Cisplatin—Hypersensitivity—Epirubicin—hematologic cancer	5.5e-06	4.29e-05	CcSEcCtD
Cisplatin—Body temperature increased—Doxorubicin—hematologic cancer	5.46e-06	4.26e-05	CcSEcCtD
Cisplatin—Diarrhoea—Methotrexate—hematologic cancer	5.46e-06	4.26e-05	CcSEcCtD
Cisplatin—Asthenia—Epirubicin—hematologic cancer	5.36e-06	4.18e-05	CcSEcCtD
Cisplatin—Diarrhoea—Epirubicin—hematologic cancer	5.11e-06	3.99e-05	CcSEcCtD
Cisplatin—Hypersensitivity—Doxorubicin—hematologic cancer	5.09e-06	3.97e-05	CcSEcCtD
Cisplatin—Vomiting—Methotrexate—hematologic cancer	5.07e-06	3.96e-05	CcSEcCtD
Cisplatin—Rash—Methotrexate—hematologic cancer	5.03e-06	3.93e-05	CcSEcCtD
Cisplatin—Dermatitis—Methotrexate—hematologic cancer	5.03e-06	3.92e-05	CcSEcCtD
Cisplatin—Asthenia—Doxorubicin—hematologic cancer	4.96e-06	3.87e-05	CcSEcCtD
Cisplatin—Vomiting—Epirubicin—hematologic cancer	4.75e-06	3.7e-05	CcSEcCtD
Cisplatin—Nausea—Methotrexate—hematologic cancer	4.74e-06	3.7e-05	CcSEcCtD
Cisplatin—Diarrhoea—Doxorubicin—hematologic cancer	4.73e-06	3.69e-05	CcSEcCtD
Cisplatin—Rash—Epirubicin—hematologic cancer	4.71e-06	3.67e-05	CcSEcCtD
Cisplatin—Dermatitis—Epirubicin—hematologic cancer	4.7e-06	3.67e-05	CcSEcCtD
Cisplatin—Nausea—Epirubicin—hematologic cancer	4.44e-06	3.46e-05	CcSEcCtD
Cisplatin—Vomiting—Doxorubicin—hematologic cancer	4.39e-06	3.43e-05	CcSEcCtD
Cisplatin—Rash—Doxorubicin—hematologic cancer	4.36e-06	3.4e-05	CcSEcCtD
Cisplatin—Dermatitis—Doxorubicin—hematologic cancer	4.35e-06	3.4e-05	CcSEcCtD
Cisplatin—Nausea—Doxorubicin—hematologic cancer	4.1e-06	3.2e-05	CcSEcCtD
Cisplatin—CYP2C9—Metabolism—GSTO1—hematologic cancer	1.33e-06	1.75e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ABCC3—hematologic cancer	1.33e-06	1.75e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—TXN—hematologic cancer	1.33e-06	1.75e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ABCB1—hematologic cancer	1.33e-06	1.74e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PTEN—hematologic cancer	1.32e-06	1.72e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.31e-06	1.72e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—GRB2—hematologic cancer	1.31e-06	1.72e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PDGFA—hematologic cancer	1.31e-06	1.72e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SLC22A1—hematologic cancer	1.31e-06	1.71e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CRABP1—hematologic cancer	1.31e-06	1.71e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SPHK1—hematologic cancer	1.3e-06	1.71e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—NCOR1—hematologic cancer	1.3e-06	1.71e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GSTM1—hematologic cancer	1.3e-06	1.71e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—CREBBP—hematologic cancer	1.3e-06	1.71e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CD44—hematologic cancer	1.3e-06	1.7e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—NQO1—hematologic cancer	1.3e-06	1.7e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—KITLG—hematologic cancer	1.29e-06	1.69e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—NCOR1—hematologic cancer	1.29e-06	1.69e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GSTM1—hematologic cancer	1.29e-06	1.69e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MAPK3—hematologic cancer	1.29e-06	1.69e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—MTHFR—hematologic cancer	1.28e-06	1.67e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ALOX5—hematologic cancer	1.27e-06	1.67e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.27e-06	1.67e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.27e-06	1.67e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PIK3CB—hematologic cancer	1.27e-06	1.66e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—STAT5A—hematologic cancer	1.26e-06	1.66e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PTEN—hematologic cancer	1.26e-06	1.65e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—EP300—hematologic cancer	1.25e-06	1.64e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—UGT1A1—hematologic cancer	1.25e-06	1.64e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CDKN2B—hematologic cancer	1.25e-06	1.64e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MYC—hematologic cancer	1.25e-06	1.64e-05	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PIK3CA—hematologic cancer	1.25e-06	1.64e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—TGFB1—hematologic cancer	1.25e-06	1.64e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—NQO1—hematologic cancer	1.25e-06	1.63e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CD44—hematologic cancer	1.25e-06	1.63e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CD—hematologic cancer	1.23e-06	1.62e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NUP98—hematologic cancer	1.23e-06	1.61e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CYCS—hematologic cancer	1.23e-06	1.61e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—HSP90AA1—hematologic cancer	1.22e-06	1.6e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CRABP1—hematologic cancer	1.22e-06	1.6e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SLC22A1—hematologic cancer	1.22e-06	1.6e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—ALB—hematologic cancer	1.22e-06	1.6e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CD86—hematologic cancer	1.21e-06	1.59e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—EP300—hematologic cancer	1.2e-06	1.58e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ADCY7—hematologic cancer	1.2e-06	1.57e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NCOA3—hematologic cancer	1.2e-06	1.57e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HES1—hematologic cancer	1.19e-06	1.57e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ALOX5—hematologic cancer	1.19e-06	1.56e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NUP214—hematologic cancer	1.19e-06	1.56e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NCOR1—hematologic cancer	1.19e-06	1.56e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYCS—hematologic cancer	1.18e-06	1.55e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FGF1—hematologic cancer	1.17e-06	1.54e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—HSP90AA1—hematologic cancer	1.17e-06	1.54e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3R1—hematologic cancer	1.17e-06	1.53e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ABCG2—hematologic cancer	1.16e-06	1.52e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—MTR—hematologic cancer	1.16e-06	1.52e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FOXO1—hematologic cancer	1.16e-06	1.52e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—KRAS—hematologic cancer	1.16e-06	1.52e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PDGFRB—hematologic cancer	1.16e-06	1.51e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—MTHFR—hematologic cancer	1.15e-06	1.51e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NUP98—hematologic cancer	1.15e-06	1.51e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ENO2—hematologic cancer	1.14e-06	1.5e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—MTHFR—hematologic cancer	1.14e-06	1.49e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PDGFRA—hematologic cancer	1.14e-06	1.49e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—JAK1—hematologic cancer	1.13e-06	1.49e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PRKCG—hematologic cancer	1.13e-06	1.49e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.13e-06	1.47e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NCOA3—hematologic cancer	1.12e-06	1.46e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ADCY7—hematologic cancer	1.12e-06	1.46e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NUP214—hematologic cancer	1.11e-06	1.45e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTT1—hematologic cancer	1.11e-06	1.45e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.1e-06	1.44e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.1e-06	1.44e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PTEN—hematologic cancer	1.09e-06	1.43e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—MTR—hematologic cancer	1.09e-06	1.42e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ABCG2—hematologic cancer	1.09e-06	1.42e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GSTP1—hematologic cancer	1.08e-06	1.42e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SDC1—hematologic cancer	1.08e-06	1.42e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CB—hematologic cancer	1.08e-06	1.41e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.07e-06	1.41e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CG—hematologic cancer	1.07e-06	1.41e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ENO2—hematologic cancer	1.07e-06	1.4e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PIK3CA—hematologic cancer	1.06e-06	1.39e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PIK3CA—hematologic cancer	1.06e-06	1.39e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MTHFR—hematologic cancer	1.05e-06	1.38e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.05e-06	1.37e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TERT—hematologic cancer	1.05e-06	1.37e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HLA-A—hematologic cancer	1.05e-06	1.37e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—EP300—hematologic cancer	1.04e-06	1.37e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GSTP1—hematologic cancer	1.04e-06	1.36e-05	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.04e-06	1.36e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PIK3CA—hematologic cancer	1.03e-06	1.36e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTT1—hematologic cancer	1.03e-06	1.35e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ABCB1—hematologic cancer	1.02e-06	1.34e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PDGFB—hematologic cancer	1.02e-06	1.34e-05	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—AKT1—hematologic cancer	1.02e-06	1.34e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.02e-06	1.33e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SDC1—hematologic cancer	1.01e-06	1.32e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TSC2—hematologic cancer	9.98e-07	1.31e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CREBBP—hematologic cancer	9.95e-07	1.3e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GSTM1—hematologic cancer	9.94e-07	1.3e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—NCOR1—hematologic cancer	9.94e-07	1.3e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ABCB1—hematologic cancer	9.84e-07	1.29e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—HRAS—hematologic cancer	9.83e-07	1.29e-05	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	9.7e-07	1.27e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CG—hematologic cancer	9.68e-07	1.27e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	9.65e-07	1.27e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FGFR3—hematologic cancer	9.6e-07	1.26e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CG—hematologic cancer	9.58e-07	1.26e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GSTM1—hematologic cancer	9.56e-07	1.25e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—NCOR1—hematologic cancer	9.56e-07	1.25e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	9.53e-07	1.25e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CD—hematologic cancer	9.43e-07	1.24e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—IL6—hematologic cancer	9.41e-07	1.23e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—ALB—hematologic cancer	9.31e-07	1.22e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTEN—hematologic cancer	9.3e-07	1.22e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PIK3CA—hematologic cancer	9.28e-07	1.22e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NQO1—hematologic cancer	9.2e-07	1.21e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CD44—hematologic cancer	9.2e-07	1.21e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	9.11e-07	1.19e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—BAD—hematologic cancer	9.1e-07	1.19e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NOTCH1—hematologic cancer	9.02e-07	1.18e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CREBBP—hematologic cancer	8.98e-07	1.18e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3R1—hematologic cancer	8.91e-07	1.17e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PIK3CA—hematologic cancer	8.9e-07	1.17e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CREBBP—hematologic cancer	8.88e-07	1.16e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—EP300—hematologic cancer	8.87e-07	1.16e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CD80—hematologic cancer	8.83e-07	1.16e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—KIT—hematologic cancer	8.82e-07	1.16e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—MTHFR—hematologic cancer	8.79e-07	1.15e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYCS—hematologic cancer	8.7e-07	1.14e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—AKT1—hematologic cancer	8.68e-07	1.14e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—AKT1—hematologic cancer	8.67e-07	1.14e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PTPN11—hematologic cancer	8.66e-07	1.14e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—HSP90AA1—hematologic cancer	8.65e-07	1.13e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CD44—hematologic cancer	8.59e-07	1.13e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NQO1—hematologic cancer	8.59e-07	1.13e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CD—hematologic cancer	8.51e-07	1.12e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—AKT1—hematologic cancer	8.45e-07	1.11e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—MTHFR—hematologic cancer	8.45e-07	1.11e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CD—hematologic cancer	8.42e-07	1.1e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	8.41e-07	1.1e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ALB—hematologic cancer	8.4e-07	1.1e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CREB1—hematologic cancer	8.39e-07	1.1e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ALB—hematologic cancer	8.31e-07	1.09e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—BRAF—hematologic cancer	8.29e-07	1.09e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CB—hematologic cancer	8.22e-07	1.08e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—IL6R—hematologic cancer	8.19e-07	1.07e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CREBBP—hematologic cancer	8.17e-07	1.07e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYCS—hematologic cancer	8.13e-07	1.07e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	8.08e-07	1.06e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3R1—hematologic cancer	8.04e-07	1.05e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3R1—hematologic cancer	7.95e-07	1.04e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MAP2K1—hematologic cancer	7.8e-07	1.02e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PIK3CD—hematologic cancer	7.75e-07	1.02e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	7.74e-07	1.02e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PIK3CA—hematologic cancer	7.71e-07	1.01e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTP1—hematologic cancer	7.67e-07	1.01e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—AKT1—hematologic cancer	7.58e-07	9.94e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FGF2—hematologic cancer	7.42e-07	9.73e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CB—hematologic cancer	7.42e-07	9.72e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CG—hematologic cancer	7.38e-07	9.68e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CB—hematologic cancer	7.34e-07	9.62e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PIK3R1—hematologic cancer	7.32e-07	9.59e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.27e-07	9.53e-06	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—AKT1—hematologic cancer	7.27e-07	9.53e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTP1—hematologic cancer	7.17e-07	9.39e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—JAK2—hematologic cancer	7.11e-07	9.32e-06	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTEN—hematologic cancer	7.1e-07	9.31e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CG—hematologic cancer	7.1e-07	9.3e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTM1—hematologic cancer	7.05e-07	9.24e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NCOR1—hematologic cancer	7.05e-07	9.24e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MDM2—hematologic cancer	6.94e-07	9.1e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.93e-07	9.09e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CREBBP—hematologic cancer	6.85e-07	8.97e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ABCB1—hematologic cancer	6.78e-07	8.89e-06	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—EP300—hematologic cancer	6.77e-07	8.88e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MTOR—hematologic cancer	6.76e-07	8.85e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PIK3CB—hematologic cancer	6.76e-07	8.85e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CD4—hematologic cancer	6.74e-07	8.84e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NCOR1—hematologic cancer	6.59e-07	8.63e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTM1—hematologic cancer	6.59e-07	8.63e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CREBBP—hematologic cancer	6.58e-07	8.62e-06	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CA—hematologic cancer	6.56e-07	8.6e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CD—hematologic cancer	6.49e-07	8.51e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTEN—hematologic cancer	6.41e-07	8.4e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ALB—hematologic cancer	6.41e-07	8.4e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTEN—hematologic cancer	6.34e-07	8.31e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CDKN1B—hematologic cancer	6.34e-07	8.31e-06	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—AKT1—hematologic cancer	6.3e-07	8.26e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CD—hematologic cancer	6.24e-07	8.18e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—MTHFR—hematologic cancer	6.23e-07	8.17e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ALB—hematologic cancer	6.16e-07	8.07e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3R1—hematologic cancer	6.13e-07	8.03e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—EP300—hematologic cancer	6.11e-07	8.01e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—EP300—hematologic cancer	6.05e-07	7.93e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3R1—hematologic cancer	5.89e-07	7.72e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CDKN1A—hematologic cancer	5.85e-07	7.67e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PTEN—hematologic cancer	5.84e-07	7.65e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—MTHFR—hematologic cancer	5.82e-07	7.63e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CB—hematologic cancer	5.66e-07	7.42e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EP300—hematologic cancer	5.57e-07	7.3e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CB—hematologic cancer	5.44e-07	7.13e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SRC—hematologic cancer	5.41e-07	7.1e-06	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—AKT1—hematologic cancer	5.36e-07	7.02e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CG—hematologic cancer	5.23e-07	6.86e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—STAT3—hematologic cancer	5.22e-07	6.84e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NRAS—hematologic cancer	5.21e-07	6.83e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.13e-07	6.72e-06	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CA—hematologic cancer	5.01e-07	6.57e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MAPK3—hematologic cancer	4.99e-07	6.54e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CG—hematologic cancer	4.89e-07	6.41e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PTEN—hematologic cancer	4.89e-07	6.41e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CREBBP—hematologic cancer	4.85e-07	6.36e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MYC—hematologic cancer	4.85e-07	6.36e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TGFB1—hematologic cancer	4.84e-07	6.34e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTEN—hematologic cancer	4.7e-07	6.16e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—EP300—hematologic cancer	4.66e-07	6.11e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CD—hematologic cancer	4.6e-07	6.03e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ALB—hematologic cancer	4.54e-07	5.95e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CREBBP—hematologic cancer	4.53e-07	5.94e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CA—hematologic cancer	4.52e-07	5.93e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—KRAS—hematologic cancer	4.48e-07	5.88e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—EP300—hematologic cancer	4.48e-07	5.87e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CA—hematologic cancer	4.48e-07	5.87e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3R1—hematologic cancer	4.34e-07	5.69e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CD—hematologic cancer	4.3e-07	5.63e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ALB—hematologic cancer	4.24e-07	5.56e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PIK3CA—hematologic cancer	4.12e-07	5.4e-06	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—AKT1—hematologic cancer	4.09e-07	5.37e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3R1—hematologic cancer	4.06e-07	5.32e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CB—hematologic cancer	4.01e-07	5.26e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HRAS—hematologic cancer	3.81e-07	4.99e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CB—hematologic cancer	3.75e-07	4.91e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—AKT1—hematologic cancer	3.69e-07	4.84e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—AKT1—hematologic cancer	3.66e-07	4.79e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—IL6—hematologic cancer	3.65e-07	4.78e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTEN—hematologic cancer	3.47e-07	4.54e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CA—hematologic cancer	3.45e-07	4.52e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—AKT1—hematologic cancer	3.36e-07	4.41e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CA—hematologic cancer	3.31e-07	4.34e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—EP300—hematologic cancer	3.31e-07	4.33e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTEN—hematologic cancer	3.24e-07	4.24e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—EP300—hematologic cancer	3.09e-07	4.05e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—AKT1—hematologic cancer	2.82e-07	3.69e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—AKT1—hematologic cancer	2.71e-07	3.55e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CA—hematologic cancer	2.44e-07	3.2e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CA—hematologic cancer	2.28e-07	2.99e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—AKT1—hematologic cancer	2e-07	2.62e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—AKT1—hematologic cancer	1.87e-07	2.45e-06	CbGpPWpGaD
